Accelerated market access for COVID-19 related devices

In response to the COVID-19 outbreak, many medical device market regulators are releasing Emergency Use Authorizations (EUAs) and expedited regulatory pathways for devices healthcare providers need most, including ventilators, face masks and PPE, and test kits, among others. Some authorities are reclassifying products to streamline market entry and avoid shortages. The situation is changing rapidly, and Emergo by UL is committed to monitoring these developments to deliver regulatory news and intelligence that helps medical device companies respond quickly to COVID-19. 

COVID-19 resources from Emergo

How we help

Emergo consultants are monitoring emergency use developments in markets affected by COVID-19. View all markets >

Medical Device and IVD Emergency Use Routes in Europe

In response to the COVID-19 outbreak, the EC has temporarily allowed the marketing of non-CE marked personal respiratory protective equipment, certain medical devices and IVDs, and biocides.

US FDA Emergency Use Pathways for Medical Devices and IVDs

The US FDA has declared the COVID-19 outbreak to be a public health emergency and invoked their authorities for Emergency Use Authorization (EUA), through which the FDA Commissioner may allow unapproved medical devices to be used for emergency applications.

Mexico Emergency Use Pathways for Medical Devices and IVDs

In light of the current COVID-19 emergency, COFEPRIS has published two official communications (March 26 and April 17) regarding its policies during this time, stating that all administrative terms and deadlines are to be stopped between March 26 and April 30, in order to deploy resources to perform essential functions related to COVID-19.

Remote Usability Testing Helps Ensure Effective Medical Device Use

A number of rapid, remote assessments, such as optimizing user interface, creating instructions for use, and usability test, can be performed to help ensure products are used safely and effectively.

Australia Emergency Use Pathways for Medical Devices

In response to the COVID-19 outbreak, the TGA has emergency exemptions that allow for the importation and sale of some devices, including COVID-19 IVD test kits, and products without the normal registration requirements, or expedited registrations, where applicable.

Mitigating Cybersecurity Risks in Emergency Situations

Medical device companies working to address COVID-19 need to mitigate cybersecurity risks associated with managing the outbreak.

Blog

Get the latest medical device regulatory news on COVID-19. View All

Jan 6, 2021

US FDA provides extra response time for device submissions on hold and expands virtual options

An updated guidance document extends the deadline for companies to deal with applications and submissions...

READ MORE
Jan 5, 2021

Health Canada explains plans for COVID-19 Interim Orders and forthcoming regulatory amendments

The agency plans to maintain continuity and ensure a blend of flexibility and regulatory oversight...

READ MORE
Dec 17, 2020

Cold chain management for COVID-19 vaccines: Ensuring safe and effective distribution

Considerations for heathcare providers and other stakeholders involved in vaccine cold chain processes

READ MORE
Dec 8, 2020

EC Q&A clarifies guidelines for medical device remote audits

The new guidance document expands on MDCG 2020-17’s advice for conducting virtual audits of medical...

READ MORE
Dec 2, 2020

In brief: Health Canada will leave COVID-19 Interim Orders in place until fall 2021

The Canadian regulator seeks to ensure stability by continuing its current emergency measures and by...

READ MORE

COVID-19 resources

Get the most recent content from our resource library on COVID-19. View All